Phlebologie 2020; 49(01): 16-22
DOI: 10.1055/a-0865-5296
Review
© Georg Thieme Verlag KG Stuttgart · New York

Selective photothermolysis of spider veins and reticular varices with the long-pulsed Nd:YAG laser

Article in several languages: English | deutsch
A. A. M. Fratila
1   Jungbrunnen-Klinik GmbH, Bonn
,
G. G. Gauglitz
2   Klinik and Poliklinik für Dermatologie and Allergologie, Ludwig-Maximilians-Universität München
,
A. Strohbücker
1   Jungbrunnen-Klinik GmbH, Bonn
,
D. Radu
3   Clinica 1 Chirurgie, Universitatea de Medicina si Farmacie Victor Babes, Timisoara, Romania
› Author Affiliations
Further Information

Publication History

28 June 2018

16 January 2019

Publication Date:
07 June 2019 (online)

Abstract

The therapy of spider veins, telangiectasia and reticular veins of lower extremities can be successfully performed with sclerotherapy or by using the long pulsed (LP) Nd:YAG laser. A matter of discussion, however, is how should laser parameters – such as wavelength, fluence, pulse duration, number of pulses – be utilized for effective and selective photothermolysis treatment without any side effects. The selective photothermolysis was introduced in 1983 by Anderson and Parrish [1] as a concept in laser treatment, meaning the selective thermal destruction of the target tissue (the chromophores – the light-absorption molecule is here the blood vessel) using a specific laser light wavelength, with minimal injury to surrounding tissue (the skin). The effectiveness of the selective photothermolysis process using an LP Nd:YAG laser at 1064 nm for the treatment of leg veins telangiectasias up to 2 mm in diameter, is the result of 30-years clinical experience sustained by patient satisfaction and photo documentation. The use of double and triple pulses seems to be the key of success in treating even larger vessels and has demonstrated superior safety and efficacy. Even bigger telangiectasias, reticular veins or other dilated veins on neckline, upper abdomen or in the face can be successfully treated with the LP Nd:YAG laser.

 
  • References

  • 1 Anderson RR, Parrish JA. Selective photothermolysis: precise microsurgery by selective absorption of pulse radiation. Science 1983; 220: 524-727
  • 2 Parlar B, Blazek C, Cazzaniga S. et al. Treatment of lower extremity telangiectasias in women by foam sclerotherapy vs. Nd:YAG laser: a prospective, comparative, randomized, open-label trial. JEADV 2014
  • 3 Lohr JM, Bush RL. Venous disease in women: Epidemiology, manifestations, and treatment. J Vasc Surg 2013; 57: 37-45
  • 4 Munia MA, Wolosker N, Munia CG. et al. Comparison of laser versus sclerotherapy in the treatment of lower extremity teleangiectases: a prospective study. Dermatol Surg 2012; 38: 635-639
  • 5 Meissner MH. Lower extremity venous anatomy. Semin Intervent Radiol 2005; 22 (03) 147-156
  • 6 Ross EV, Domankevitz Y. laser Treatment of Leg Veins: Physical Mechanisms and Theoretical Considerations lasers Surg. Med 2005; 36: 105-116
  • 7 Lumenis®, Wittig C. Leg veins – Long-pulsed (LP) Nd:YAG Guidelines/CD-1008960 Rev A 2017.
  • 8 Gloviczki P, Comerota AJ, Dalsing MC. et al. Society for Vascular Surgery; American Venous Forum. The care of patients with varicose veins and associated chronic venous diseases: Clinical practice guidelines of the Society for Vascular Surgery and the American Venous Forum. J Vasc Surg 2011; 53: 2-48
  • 9 Eremia S, Li C, Umar SH. A side-by-side comparative study of 1064 nm Nd:YAG, 810 nm diode and 755 nm alexandrite lasers for treatment of 0.3–3 mm leg veins. Dermatologic Surgery 2002; 28 (03) 224-230
  • 10 Dover JS, Sadick NS, Goldman MP. The role of laser s and light sources in the treatment of leg veins. Dermatol Surg 1999; 25: 328-335
  • 11 Adamic M, Troilius A, Adatto M. et al. Vascular laser s and IPLS: Guidelines for care from the European Society for Laser Dermatology. J Cosmet Laser Ther 2007; 9: 113-124
  • 12 Sadick NS, Weiss RA, Goldman MP. Advances in laser surgery for leg veins: Bimodal wavelength approach to lower extremity vessels, new cooling techniques and longer pulse durations. Dermatol Surg 2002; 28: 16-20
  • 13 Levy JL, Elbahr C, Jouve E. et al. Comparison and sequential study of long pulsed Nd:YAG 1,064 nm laser and sclerotherapy in leg telangiectasias treatment. Lasers in Surgery and Medicine 2004; 34: 273-276
  • 14 Trelles MA, Allones I, Martín-Vázquez MJ. et al. Long pulse Nd:YAG laser for treatment of leg veins in 40 Patients with assessments at 6 and 12 months. Lasers in Surgery and Medicine 2004; 35: 68-76
  • 15 Bäumler W, Ulrich H, Hartl A. et al. Optimal parameters for the treatment of leg veins using Nd:YAG lasers at 1064 nm. British Journal of Dermatology 2006; 155: pp364-pp371
  • 16 Randeberg LL, Bonesrønning JH, Dalaker M. et al. Methaemoglobin formation during laser-induced photothermolysis of vascular skin lesions. Lasers Surg Med 2004; 34: 414-419
  • 17 Black JF, Barton JK. Chemical and structural changes in blood undergoing laser photocoagulation. Photochemistry and Photobiology 2004; 80: 89-97
  • 18 Mordon S, Brisot D, Fournier N. Using a “non uniform pulse sequence” can improve selective coagulation with a Nd:YAG laser (1.06 mm) thanks to Met-hemoglobin absorption: a clinical study on blue leg veins. Lasers in Surgery and Medicine 2003; 32: 160-170
  • 19 Parlette EC, Groff WF, Kinshella MJ. et al. Optimal pulse durations for the treatment of legtelangiectasias with a Neodymium YAG laser. Lasers in Surgery and Medicine 2006; 38: 98-105